Citi, BofA-backed Amgen raises hopes of 2023 M&A bonanza
An end-of-year surge in deal-making has sparked predictions of a boom in leveraged buy-outs
Unlock this article.
The content you are trying to view is exclusive to our subscribers.
To unlock this article: